| Geld/Brief | 87,95 $ / 135,68 $ |
| Spread | +54,27% |
| Schluss Vortag | 107,01 $ |
| Gehandelte Stücke | 108.257 |
| Tagesvolumen Vortag | 4.623.815 $ |
| Tagestief 102,42 $ Tageshoch 106,25 $ | |
| 52W-Tief 36,95 $ 52W-Hoch 129,80 $ | |
| Jahrestief 66,35 $ Jahreshoch 129,80 $ | |
| Umsatz in Mio. | 39,20 $ |
| Operatives Ergebnis (EBIT) in Mio. | -349,40 $ |
| Jahresüberschuss in Mio. | -311,40 $ |
| Umsatz je Aktie | 0,46 $ |
| Gewinn je Aktie | -3,69 $ |
| Gewinnrendite | -794,39% |
| Umsatzrendite | -794,39% |
| Return on Investment | -17,87% |
| Marktkapitalisierung in Mio. | 9.052 $ |
| KGV (Kurs/Gewinn) | -21,09 |
| KBV (Kurs/Buchwert) | 4,16 |
| KUV (Kurs/Umsatz) | 169,15 |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | +90,64% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| AMEX | 108,22 $ | - | - | 29.07.26 | |
| Nasdaq | 103,39 $ | -3,38% | 107,01 $ | 31.07.26 | |
| NYSE | 103,19 $ | -3,43% | 106,86 $ | 31.07.26 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 31.07.26 | 103,40 | 4,62 M |
| 30.07.26 | 107,01 | 3,63 M |
| 29.07.26 | 105,25 | 4,26 M |
| 28.07.26 | 106,16 | 8,19 M |
| 27.07.26 | 110,05 | 19,5 M |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 110,57 $ | -6,49% |
| 1 Monat | 114,20 $ | -9,47% |
| 6 Monate | 72,69 $ | +42,23% |
| 1 Jahr | 43,77 $ | +136,21% |
| 5 Jahre | 60,18 $ | +71,80% |
| Marktkapitalisierung | 9,05 Mrd. $ |
| Streubesitz | 79,22% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Biotechnologie |
| Aktientyp | Stammaktie |
| +9,59% | T. Rowe Price Associates, Inc. |
| +9,30% | Baker Bros Advisors LP |
| +9,17% | venBio Select Advisor LLC |
| +7,86% | Vanguard Group Inc |
| +7,70% | Bvf Inc |
| +7,60% | FMR Inc |
| +7,51% | Wellington Management Company LLP |
| +5,80% | BlackRock Inc |
| +5,71% | Atlas Venture Life Science Advisors, LLC |
| +4,79% | Siren, L.L.C. |
| +4,06% | US Small-Cap Growth II Equity Comp |
| +3,73% | T. Rowe Price New Horizons |
| +3,50% | Vanguard Capital Management, LLC |
| +3,49% | Vanguard Portfolio Management, LLC |
| +3,34% | Vanguard Health Care Inv |
| +3,29% | Fidelity Growth Compy Commingled Pl S |
| +2,63% | Vanguard Total Stock Mkt Idx Inv |
| +2,30% | Fidelity Growth Company Fund |
| +2,17% | State Street Corp |
| +2,03% | Vanguard Small Cap Index |
| +1,77% | Capital Research Global Investors |
| +1,69% | T. Rowe Price Health Sciences |
| +1,67% | Geode Capital Management, LLC |
| +1,58% | iShares Russell 2000 ETF |
| +1,56% | American Funds SMALLCAP World A |
| +1,37% | Vanguard Explorer Inv |
| +1,31% | Driehaus Capital Management LLC |
| +1,30% | T. Rowe Price New Horizons Tr-A |
| +1,24% | State Street® SPDR® S&P® Biotech ETF |
| +1,17% | AllianceBernstein L.P. |
| +1,15% | UBS Asset Mgmt Americas Inc |
| +1,15% | Jennison Associates LLC |
| +1,14% | Vanguard Small Cap Growth Index Inv |
| +1,12% | Redmile Group, LLC |
| +1,08% | Merck & Co Inc |
| +1,05% | COMMODORE CAPITAL LP |
| +0,97% | T. Rowe Price US Small-Cap Core Equity |
| +0,97% | T. Rowe Price Small-Cap Stock |
| +0,94% | Federated Hermes Inc |
| +0,93% | Holocene Advisors, LP |
| +0,91% | Deerfield Management Co |
| +0,89% | T. Rowe Price Investment Management,Inc. |
| +0,87% | The Goldman Sachs Group Inc |
| +0,80% | T. Rowe Price US All-Cap Opp Eq Comp |
| +0,80% | T. Rowe Price All-Cap Opportunities Fund |
| +0,80% | T. Rowe Price Integrated US SmCapGrEq |
| +0,79% | UBS Group AG |
| +0,79% | Eventide Healthcare & Life Sciences I |
| +0,79% | Dimensional Fund Advisors, Inc. |
| +0,78% | Vanguard Institutional Extnd Mkt Idx Tr |
| +0,75% | T. Rowe Price Integrated US Sm Gr Eq |
| +0,74% | Fidelity Contrafund |
| +0,73% | PGIM Jennison Health Sciences Z |
| +0,73% | Jennison Health Sciences Equity |
| +0,71% | Fidelity Growth Company K6 |
| +0,68% | Fidelity Small Cap Index |
| +0,68% | SPDR® S&P Biotech ETF |
| +107,47% | Institutionelle Aktionäre |
| +79,22% | Streubesitz |
| -28,26% | Individuelle Aktionäre |
